Prediabetes is a condition in which blood glucose levels are higher than normal but not high enough to be diagnosed as diabetes. Individuals with prediabetes are considered at high risk for developing type 2 diabetes. In addition, they have an increased risk of cardiovascular and cerebrovascular diseases because people with prediabetes often have other metabolic abnormalities, including hypertension, dyslipidemia, overweight, or obesity, collectively known as metabolic syndrome. However, if indi
Conditions
Interventions
Self regulation program for prevention of new onset diabetes is an 12 week lifestyle intervention based on Bandura self regulation theory. The program consists of three components. 1) Self observation
Experimental Behavioral,No Intervention Other
Self-regulation program for prevention of new-onset diabetes,Usual care
Sponsors
khaosukim hospital
Eligibility
Sex/Gender
All
Age
35 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients with hypertension both male and female aged 35 years and older, 2.Fasting plasma glucose levels between 100 to 125 mg per dL, 3.Able to communicate in Thai read and write and have a mobile phone capable of using LINE
Exclusion criteria
Exclusion criteria: 1.Patients with hypertension who are taking thiazide diuretics such as HCTZ or beta blockers such as propranolol, 2.Having comorbidities related to the pancreas such as pancreatitis pancreatectomy trauma or neoplasia, 3.Having comorbidities related to the endocrine system such as Cushing syndrome acromegaly or hyperthyroidism, 4.Taking medications such as glucocorticoids HIV antiviral drugs fluoroquinolone antibiotics or phenytoin, 5.Undergoing chemotherapy or immunosuppressive therapy after organ transplantation, 6.Psychiatric patients taking antipsychotic drugs such as clonazepam or antidepressants from the SGA group, 8.Pregnant or having a history of diabetes during pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dietary behavior score Baseline and week 12 Mean score of dietary behavior questionnaire validated for prediabetes patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose Baseline and week 12 FPG measured in mg/dL using standard laboratory method | — |
Countries
Thailand
Contacts
Public Contactnattaya iamsakul
khaosukim hospital
Outcome results
None listed